The Latest Analyst Ratings for Precision BioSciences
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 analysts have published bullish opinions on Precision BioSciences (NASDAQ:DTIL) stock. The average price target is $6.75, which is significantly higher than the current price of $0.525. However, this represents a 27.65% decrease from the previous average price target of $9.33.
August 17, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have a bullish outlook on Precision BioSciences (NASDAQ:DTIL) with a price target significantly higher than the current price, despite a decrease from the previous target.
The bullish outlook from analysts indicates a positive sentiment towards the stock. The significant difference between the current price and the average price target suggests potential for growth. However, the decrease from the previous target may indicate some caution.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100